NuvOx Pharma: Funding, Investors & Team (Sep 2026)
Located in Tucson, Arizona, NuvOx Pharma is a biotechnology business that is creating a first-of-its-kind oxygen therapy to cure fatal diseases where hypoxia is a factor. Seven different indications have seen a therapeutic impact in more than 30 animal investigations. The company is getting ready to conduct a Phase IIa trial in COVID-19 patients with Acute Hypoxemic Respiratory Failure after Phase Ib/II clinical trials in oncology and stroke showed safety and evidence of efficacy (AHRF) Diane Fairfield painted the image for the cover.
NuvOx Pharma has raised $1.1M across 1 funding round on record, the most recent an undisclosed round of $1.1M announced in Feb 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
NuvOx Pharma Company Profile and Key Stats
Latest funding round on record: Feb 2023.
NuvOx Pharma Funding Rounds
NuvOx Pharma Founders and Leadership Team
Contact details for the NuvOx Pharma team: 1 of 1 has an email address on file.
Start 14-day free trial →NuvOx Pharma Funding Compared to Other Biotechnology Startups
NuvOx Pharma's latest round of $1.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NuvOx Pharma in Biotechnology and Tucson
Companies Similar to NuvOx Pharma
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
NuvOx Pharma Funding FAQs
What does NuvOx Pharma do?
Located in Tucson, Arizona, NuvOx Pharma is a biotechnology business that is creating a first-of-its-kind oxygen therapy to cure fatal diseases where hypoxia is a factor. Seven different indications have seen a therapeutic impact in more than 30 animal investigations. The company is getting ready to conduct a Phase IIa trial in COVID-19 patients with Acute Hypoxemic Respiratory Failure after Phase Ib/II clinical trials in oncology and stroke showed safety and evidence of efficacy (AHRF) Diane Fairfield painted the image for the cover.
How much funding has NuvOx Pharma raised?
NuvOx Pharma has raised $1.1M across 1 round on record. The most recent is an undisclosed round of $1.1M announced in Feb 2023.
When did NuvOx Pharma last raise funding?
NuvOx Pharma's most recent funding round on record is an undisclosed round of $1.1M, announced in Feb 2023.
Who is the CEO of NuvOx Pharma?
Evan Unger is listed as CEO at NuvOx Pharma.
Where is NuvOx Pharma headquartered?
NuvOx Pharma is based in Tucson, Arizona, United States.
How many employees does NuvOx Pharma have?
NuvOx Pharma is in the 11-50 employee band.
How does NuvOx Pharma's funding compare to other Biotechnology startups?
NuvOx Pharma's latest round of $1.1M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's NuvOx Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NuvOx Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.